{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:23:19Z","timestamp":1760865799167},"reference-count":56,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2013,8,18]],"date-time":"2013-08-18T00:00:00Z","timestamp":1376784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00005-013-0248-8","type":"journal-article","created":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T05:45:01Z","timestamp":1376718301000},"page":"23-30","source":"Crossref","is-referenced-by-count":3,"title":["Functional Attributes of Responding T Cells in HCV Infection: The Recent Advances in Engineering Functional Antiviral T Cells"],"prefix":"10.2478","volume":"62","author":[{"given":"Anna","family":"Pasetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2013,8,18]]},"reference":[{"key":"248_CR1","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.1128\/JVI.01094-10","volume":"84","author":"MS Abdel-Hakeem","year":"2010","unstructured":"Abdel-Hakeem MS, Bedard N, Badr G et al (2010) Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus. J Virol 84:10429\u201310435","journal-title":"J Virol"},{"key":"248_CR2","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1182\/blood-2009-10-251124","volume":"115","author":"C Alanio","year":"2010","unstructured":"Alanio C, Lemaitre F, Law HK et al (2010) Enumeration of human antigen-specific naive CD8\u00a0+\u00a0T cells reveals conserved precursor frequencies. Blood 115:3718\u20133725","journal-title":"Blood"},{"key":"248_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri1550","volume":"5","author":"R Antia","year":"2005","unstructured":"Antia R, Ganusov VV, Ahmed R (2005) The role of models in understanding CD8\u00a0+\u00a0T-cell memory. Nat Rev Immunol 5:101\u2013111","journal-title":"Nat Rev Immunol"},{"key":"248_CR4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.f.1774","volume":"14","author":"V Appay","year":"2008","unstructured":"Appay V, Douek DC, Price DA (2008) CD8\u00a0+\u00a0T cell efficacy in vaccination and disease. Nat Med 14:623\u2013628","journal-title":"Nat Med"},{"key":"248_CR5","doi-asserted-by":"crossref","first-page":"10017","DOI":"10.1128\/JVI.01083-08","volume":"82","author":"G Badr","year":"2008","unstructured":"Badr G, Bedard N, Abdel-Hakeem MS et al (2008) Early interferon therapy for hepatitis C virus infection rescues poly-functional, long-lived CD8\u00a0+\u00a0memory T cells. J Virol 82:10017\u201310031","journal-title":"J Virol"},{"key":"248_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2567.2012.03574.x","volume":"136","author":"ML Bettini","year":"2012","unstructured":"Bettini ML, Bettini M, Vignali DA (2012) T-cell receptor retrogenic mice: a rapid, flexible alternative to T-cell receptor transgenic mice. Immunology 136:265\u2013272","journal-title":"Immunology"},{"key":"248_CR7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","volume":"436","author":"DG Bowen","year":"2005","unstructured":"Bowen DG, Walker CM (2005) Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946\u2013952","journal-title":"Nature"},{"key":"248_CR8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/hep.21157","volume":"43","author":"GG Callender","year":"2006","unstructured":"Callender GG, Rosen HR, Roszkowski JJ et al (2006) Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition. Hepatology 43:973\u2013981","journal-title":"Hepatology"},{"key":"248_CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","volume":"116","author":"M Chen","year":"1999","unstructured":"Chen M, Sallberg M, Sonnerborg A et al (1999) Limited humoral immunity in hepatitis C virus infection. Gastroenterology 116:135\u2013143","journal-title":"Gastroenterology"},{"key":"248_CR10","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1128\/JVI.74.16.7587-7599.2000","volume":"74","author":"M Chen","year":"2000","unstructured":"Chen M, Sallberg M, Thung SN et al (2000) Non-deletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection. J Virol 74:7587\u20137599","journal-title":"J Virol"},{"key":"248_CR11","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1073\/pnas.0406282101","volume":"101","author":"MT Chen","year":"2004","unstructured":"Chen MT, Billaud JN, Sallberg M et al (2004) A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci USA 101:14913\u201314918","journal-title":"Proc Natl Acad Sci USA"},{"key":"248_CR12","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1128\/JVI.79.5.3016-3027.2005","volume":"79","author":"M Chen","year":"2005","unstructured":"Chen M, Sallberg M, Hughes J et al (2005) Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 79:3016\u20133027","journal-title":"J Virol"},{"key":"248_CR13","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/eji.200838336","volume":"38","author":"D Ciuffreda","year":"2008","unstructured":"Ciuffreda D, Comte D, Cavassini M et al (2008) Poly-functional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 38:2665\u20132677","journal-title":"Eur J Immunol"},{"key":"248_CR14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10168","volume":"474","author":"M Dorner","year":"2011","unstructured":"Dorner M, Horwitz JA, Robbins JB et al (2011) A genetically humanized mouse model for hepatitis C virus infection. Nature 474:208\u2013211","journal-title":"Nature"},{"key":"248_CR15","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1073\/pnas.91.16.7792","volume":"91","author":"P Farci","year":"1994","unstructured":"Farci P, Alter HJ, Wong DC et al (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 91:7792\u20137796","journal-title":"Proc Natl Acad Sci USA"},{"key":"248_CR16","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.93.26.15394","volume":"93","author":"P Farci","year":"1996","unstructured":"Farci P, Shimoda A, Wong D et al (1996) Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 93:15394\u201315399","journal-title":"Proc Natl Acad Sci USA"},{"key":"248_CR17","doi-asserted-by":"crossref","unstructured":"Garrone P, Fluckiger AC, Mangeot PE et al (2011) A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques. Sci Transl Med 3: 94ra71","DOI":"10.1126\/scitranslmed.3002330"},{"key":"248_CR18","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","volume":"54","author":"MG Ghany","year":"2011","unstructured":"Ghany MG, Nelson DR, Strader DB et al (2011) An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American association for the study of liver diseases. Hepatology 54:1433\u20131444","journal-title":"Hepatology"},{"key":"248_CR19","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","volume":"109","author":"E Giang","year":"2012","unstructured":"Giang E, Dorner M, Prentoe JC et al (2012) Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci USA 109:6205\u20136210","journal-title":"Proc Natl Acad Sci USA"},{"key":"248_CR20","unstructured":"Gilead Sciences (2013) Results from Gilead phase 3 trials with Sofosbuvir. Available at http:\/\/wwwhepctrustorguk\/News_Resources\/news\/2013\/January\/Results+from+Gilead+phase+3+trials+with+sofosbuvir"},{"key":"248_CR21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","volume":"302","author":"A Grakoui","year":"2003","unstructured":"Grakoui A, Shoukry NH, Woollard DJ et al (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659\u2013662","journal-title":"Science"},{"key":"248_CR22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.19.1.65","volume":"19","author":"LG Guidotti","year":"2001","unstructured":"Guidotti LG, Chisari FV (2001) Non cytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65\u201391","journal-title":"Annu Rev Immunol"},{"key":"248_CR23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","volume":"284","author":"LG Guidotti","year":"1999","unstructured":"Guidotti LG, Rochford R, Chung J et al (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825\u2013829","journal-title":"Science"},{"key":"248_CR24","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","volume":"364","author":"IM Jacobson","year":"2011","unstructured":"Jacobson IM, McHutchison JG, Dusheiko G (2011) Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 364:2405\u20132416","journal-title":"N Engl J Med"},{"key":"248_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.coi.2010.02.005","volume":"22","author":"PS Kim","year":"2010","unstructured":"Kim PS, Ahmed R (2010) Features of responding T cells in cancer and chronic infection. Curr Opin Immunol 22:223\u2013230","journal-title":"Curr Opin Immunol"},{"key":"248_CR26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","volume":"211","author":"CA Klebanoff","year":"2006","unstructured":"Klebanoff CA, Gattinoni L, Restifo NP (2006) CD8\u00a0+\u00a0T-cell memory in tumor immunology and immunotherapy. Immunol Rev 211:214\u2013224","journal-title":"Immunol Rev"},{"key":"248_CR27","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1158\/1078-0432.CCR-11-0503","volume":"17","author":"CA Klebanoff","year":"2011","unstructured":"Klebanoff CA, Gattinoni L, Palmer DC et al (2011) Determinants of successful CD8\u00a0+\u00a0T-cell adoptive immunotherapy for large established tumors in mice. Clin Can Res 17:5343\u20135352","journal-title":"Clin Can Res"},{"key":"248_CR28","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gutjnl-2011-300620","volume":"61","author":"P Klenerman","year":"2012","unstructured":"Klenerman P, Thimme R (2012) T cell responses in hepatitis C: the good, the bad and the unconventional. Gut 61:1226\u20131234","journal-title":"Gut"},{"key":"248_CR29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.gt.3302188","volume":"11","author":"ML Lamana","year":"2004","unstructured":"Lamana ML, Bueren JA, Vicario JL et al (2004) Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer. Gen Ther 11:474\u2013482","journal-title":"Gen Ther"},{"key":"248_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","volume":"14","author":"M Law","year":"2008","unstructured":"Law M, Maruyama T, Lewis J et al (2008) Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med 14:25\u201327","journal-title":"Nat Med"},{"key":"248_CR31","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","volume":"191","author":"F Lechner","year":"2000","unstructured":"Lechner F, Wong DK, Dunbar PR et al (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499\u20131512","journal-title":"J Exp Med"},{"key":"248_CR32","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","volume":"101","author":"C Logvinoff","year":"2004","unstructured":"Logvinoff C, Major ME, Oldach D et al (2004) Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA 101:10149\u201310154","journal-title":"Proc Natl Acad Sci USA"},{"key":"248_CR33","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","volume":"134","author":"N Nakamoto","year":"2008","unstructured":"Nakamoto N, Kaplan DE, Coleclough J et al (2008) Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134:1927\u20131937","journal-title":"Gastroenterology"},{"key":"248_CR34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/432478","volume":"41","author":"DM Netski","year":"2005","unstructured":"Netski DM, Mosbruger T, Depla E et al (2005) Humoral immune response in acute hepatitis C virus infection. Clin Inf Dis 41:667\u2013675","journal-title":"Clin Inf Dis"},{"key":"248_CR35","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.22242","volume":"47","author":"C Neumann-Haefelin","year":"2008","unstructured":"Neumann-Haefelin C, Timm J, Spangenberg HC et al (2008) Virological and immunological determinants of intrahepatic virus-specific CD8\u00a0+\u00a0T-cell failure in chronic hepatitis C virus infection. Hepatology 47:1824\u20131836","journal-title":"Hepatology"},{"key":"248_CR36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.stem.2012.11.002","volume":"12","author":"T Nishimura","year":"2013","unstructured":"Nishimura T, Kaneko S, Kawana-Tachikawa A et al (2013) Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 12:114\u2013126","journal-title":"Cell Stem Cell"},{"key":"248_CR37","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.4049\/jimmunol.1201613","volume":"189","author":"A Pasetto","year":"2012","unstructured":"Pasetto A, Frelin L, Aleman S et al (2012a) TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity. J Immunol 189:4510\u20134519","journal-title":"J Immunol"},{"issue":"Pt 2","key":"248_CR38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1099\/vir.0.037903-0","volume":"93","author":"A Pasetto","year":"2012","unstructured":"Pasetto A, Frelin L, Brass A et al (2012b) Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3. J Gen Virol 93(Pt 2):247\u2013258","journal-title":"J Gen Virol"},{"key":"248_CR39","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/JVI.02021-06","volume":"81","author":"H Radziewicz","year":"2007","unstructured":"Radziewicz H, Ibegbu CC, Fernandez ML et al (2007) Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81:2545\u20132553","journal-title":"J Virol"},{"key":"248_CR40","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1128\/JVI.01075-08","volume":"82","author":"H Radziewicz","year":"2008","unstructured":"Radziewicz H, Ibegbu CC, Hon H et al (2008) Impaired hepatitis C virus (HCV)-specific effector CD8\u00a0+\u00a0T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J Virol 82:9808\u20139822","journal-title":"J Virol"},{"key":"248_CR41","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","volume":"119","author":"B Rehermann","year":"2009","unstructured":"Rehermann B (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Inv 119:1745\u20131754","journal-title":"J Clin Inv"},{"key":"248_CR42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","volume":"5","author":"B Rehermann","year":"2005","unstructured":"Rehermann B, Nascimbeni M (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5:215\u2013229","journal-title":"Nat Rev Immunol"},{"key":"248_CR43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","volume":"12","author":"NP Restifo","year":"2012","unstructured":"Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12:269\u2013281","journal-title":"Nat Rev Immunol"},{"key":"248_CR44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745\u2013763","journal-title":"Annu Rev Immunol"},{"issue":"Suppl 1","key":"248_CR45","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0168-8278(12)60010-5","volume":"56","author":"C Sarrazin","year":"2012","unstructured":"Sarrazin C, Hezode C, Zeuzem S et al (2012) Antiviral strategies in hepatitis C virus infection. J Hepatol 56(Suppl 1):S88\u2013S100","journal-title":"J Hepatol"},{"key":"248_CR46","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1128\/JVI.00093-11","volume":"85","author":"J Schmidt","year":"2011","unstructured":"Schmidt J, Neumann-Haefelin C, Altay T et al (2011) Immunodominance of HLA-A2-restricted hepatitis C virus-specific CD8\u00a0+\u00a0T cell responses is linked to naive-precursor frequency. J Virol 85:5232\u20135236","journal-title":"J Virol"},{"key":"248_CR47","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.20856","volume":"42","author":"HC Spangenberg","year":"2005","unstructured":"Spangenberg HC, Viazov S, Kersting N et al (2005) Intrahepatic CD8\u00a0+\u00a0T-cell failure during chronic hepatitis C virus infection. Hepatology 42:828\u2013837","journal-title":"Hepatology"},{"key":"248_CR48","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663\u2013676","journal-title":"Cell"},{"key":"248_CR49","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","volume":"194","author":"R Thimme","year":"2001","unstructured":"Thimme R, Oldach D, Chang KM et al (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395\u20131406","journal-title":"J Exp Med"},{"key":"248_CR50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2012.12.006","volume":"12","author":"R Vizcardo","year":"2013","unstructured":"Vizcardo R, Masuda K, Yamada D et al (2013) Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells. Cell Stem Cell 12:31\u201336","journal-title":"Cell Stem Cell"},{"key":"248_CR51","unstructured":"Wang A, Chandran S, Shah SA et al (2012) The stoichiometric production of IL-2 and IFN-gamma mRNA defines memory T cells that can self-renew after adoptive transfer in humans. Sci Transl Med 4: 149ra120"},{"key":"248_CR52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ (2011) T cell exhaustion. Nat Immunol 12:492\u2013499","journal-title":"Nat Immunol"},{"key":"248_CR53","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/CJI.0b013e3181e311cb","volume":"33","author":"S Yang","year":"2010","unstructured":"Yang S, Dudley ME, Rosenberg SA et al (2010) A simplified method for the clinical-scale generation of central memory-like CD8\u00a0+\u00a0T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors. J Immunother 33:648\u2013658","journal-title":"J Immunother"},{"key":"248_CR54","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00262-012-1378-2","volume":"62","author":"S Yang","year":"2012","unstructured":"Yang S, Ji Y, Gattinoni L et al (2012) Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails. Cancer Immunol Immunother 62:727\u2013736","journal-title":"Cancer Immunol Immunother"},{"key":"248_CR55","doi-asserted-by":"crossref","first-page":"e1001018","DOI":"10.1371\/journal.ppat.1001018","volume":"6","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Liu Y, Moxley KM et al (2010) Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity. PLoS Pathog 6:e1001018","journal-title":"PLoS Pathog"},{"key":"248_CR56","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1073\/pnas.0502393102","volume":"102","author":"SC Zimmerli","year":"2005","unstructured":"Zimmerli SC, Harari A, Cellerai C et al (2005) HIV-1-specific IFN-gamma\/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci USA 102:7239\u20137244","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-013-0248-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-013-0248-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-013-0248-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:47:59Z","timestamp":1704228479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-013-0248-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,18]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1007\/s00005-013-0248-8","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,18]]}}}